Premium
Disseminated Cholesterol Embolism After Coronary Artery Bypass Grafting
Author(s) -
Nakamoto Susumu,
Kaneda Toshio,
Inoue Takehiro,
Matumoto Terufumi,
Onoe Masahiko,
Kitayama Hitoshi,
Oka Hiroshi,
Zhang Zhiwei,
Otaki Masaki,
Oku Hidetaka
Publication year - 2001
Publication title -
journal of cardiac surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.428
H-Index - 58
eISSN - 1540-8191
pISSN - 0886-0440
DOI - 10.1111/j.1540-8191.2001.tb00543.x
Subject(s) - medicine , myocardial infarction , cardiology , embolism , artery , surgery , chest pain , cardiopulmonary bypass , warfarin , revascularization , atrial fibrillation
Blue toe syndrome caused by cholesterol emboli is a relatively benign disease. However, disseminated cholesterol embolism is a life‐threatening condition. We describe here the case of a 71‐year‐old female admitted because of anterior chest pain and intermittent claudication. Following cardiac catheterization, warfarin potassium was administered. However, the patient's toes soon darkened bilaterally, and BUN and creatinine levels increased from the normal value. Skin discoloration and renal failure were improved after stopping warfarin potassium administration. The patient underwent coronary artery bypass grafting and left femoropopliteal bypass. Cerebral infarction and renal failure occurred postoperatively due to disseminated cholesterol embolism. The patient died from renal failure on the 16th postoperative day without regaining consciousness following surgery. For high risk patients, interventional procedures to the ascending aorta must be avoided. When CABG cannot be avoided for coronary revascularization, off‐pump bypass and use of arterial grafts are recommended.